Drexel University Pulmonary Physicians

Pulmonology

Edward Schulman is an expert in the field of Pulmonology. He went to medical school at Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 10 awards: "Americas Top Doctors", "Fellow (FAAAAI)", "Clinical Research Scientist Award", "National Registers Whos Who in Executives and Professionals", "Best Doctors in America", "Human Lung Mast Cells: Purification and Characterization", "Fellow", "Honorable Mention, Internal Medicine Award", "AOA" and "President". Edward S. Schulman, MD is a published MD. He has 44 papers published. The most current publication "A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative." He is registered with Medicare.

Publications

---

• Heterogeneous Mixed-Lineage Differentiation of Mouse Embryonic Stem Cells Induced by Conditioned Media from A549 Cells.
• Enhanced reseeding of decellularized rodent Lungs with mouse embryonic stem cells.
• Successful treatment of chylous ascites secondary to Sarcoidosis with methotrexate.
• Obstructive sleep apnea syndrome and Asthma: the role of continuous positive airway pressure treatment.
• Adenosine 5'-triphosphate axis in Obstructive airway diseases.
• c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung Diseases.
• Obstructive sleep apnea syndrome and Asthma: what are the links?
• ATP modulates anti-IgE-induced release of histamine from human Lung mast cells.
• Human Lung mast cell activation leads to IL-13 mRNA expression and protein release.
• Pharmacologic characterization of a novel histamine receptor on human eosinophils.
• Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
• Degranulation influences heparin-associated inhibition of RT-PCR in human Lung mast cells.
• Human Lung mast cell IL-5 gene and protein expression: temporal analysis of upregulation following IgE-mediated activation.
• The role of mast cells in inflammatory responses in the Lung.
• Histochemical heterogeneity of dispersed human Lung mast cells.
• Density heterogeneity of human Lung mast cells.
• Effects of colchicine on IgE-mediated early and late airway reactions.
• A highly sensitive fluorescent micro-assay of H2O2 release from activated human leukocytes using a dihydroxyphenoxazine derivative.
• Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
• Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation.
• Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils.
• Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.
• IgE-dependent expression of interleukin-5 mRNA and protein in human Lung: modulation by dexamethasone.
• Surfactant: clinical applications.
• Treatment of tracheobronchial granular cell myoblastomas with endoscopic bipolar cautery.
• Elevated plasma histamine in Chronic uremia. Effects of ketotifen on pruritus.
• Human Lung macrophages induce histamine release from basophils and mast cells.
• Generation of leukotriene B4 by human Lung fragments and purified human Lung mast cells.
• Release of elastase from purified human Lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme.
• Identification of chondroitin sulfate E in human Lung mast cells.
• Effects of dexamethasone on mediator release from human Lung fragments and purified human Lung mast cells.
• Human Lung mast cells: purification and characterization.
• Dispersed human Lung mast cells. Pharmacologic aspects and comparison with human Lung tissue fragments.
• Biochemical analysis of initial triggering events of IgE-mediated histamine release from human Lung mast cells.
• Arachidonic acid metabolism in purified human Lung mast cells.
• Generation of leukotrienes by purified human Lung mast cells.
• Immunoglobulin E-mediated degranulation of isolated human Lung mast cells.
• Immunoglobulin E-mediated release of a kininogenase from purified human Lung mast cells.
• Lysate RNase protection method for soft tissues.
• Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and Lung mast cell histamine release.
• Differences in the volume distributions of human Lung mast cell granules and lipid bodies: evidence that the size of these organelles is regulated by distinct mechanisms.
• Differences in the behavior of cytoplasmic granules and lipid bodies during human Lung mast cell degranulation.
• Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human Lungs.

Schools

---

• Jefferson Medical College Of Thomas Jefferson University Thomas Jefferson University

• Duke University Med Center

• Johns Hopkins University

• Moffitt Hospital University Calif San Fr

Conditions Treated

---

• Asthma
• Atelectasis
• Bronchiectasis
• Bronchitis
• View All

Doctors Specialties

---

• Critical Care Medicine
• Pulmonology

Accepted Insurances

---

Awards

---

• America’s Top Doctors
• Fellow (FAAAAI)
• Clinical Research Scientist Award
• National Register’s Who’s Who in Executives and Professionals
• Best Doctors in America
• Human Lung Mast Cells: Purification and Characterization
• Fellow
• Honorable Mention, Internal Medicine Award
• AOA
• President

Education

---

• Johns Hopkins University
• UCSF
• Duke University School of Medicine
• Jefferson Medical College

Hospital

---

• Hahnemann University Hospital

Drug Facts

---

NPI NUMBER		1780627125
NPPES Provider LastName		SCHULMAN
NPPES Provider FirstName		EDWARD
NPPES Provider ZIPCode		191071519
NPPES Provider State		PA
Specialty Description		Pulmonary Disease
Total Claim Count		557.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1780627125
Last Name Of The Provider	SCHULMAN
First Name Of The Provider	EDWARD
View All

Similar Doctors

---

	Dr. Emily S. Georgitis, MD This Doctor is OpenDoctor Recommended.
	Dr. Allan I. Pack, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Daniel Jafari, MD This Doctor is OpenDoctor Recommended.
	Dr. Joanna P. Sta Cruz, MD
	Dr. Namrata Patel, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark Benjamin, MD
	Dr. Jonathan L. Gelfand, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven M. Geller, DO This Doctor is OpenDoctor Recommended.
	Dr. Kush D. Modi, MD
	Dr. Jeffrey B. Hoag, MD This Doctor is OpenDoctor Recommended.
	Dr. Shirish Amrutia, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark J. Baumel, MD
	Dr. Sarah M. Lyon, MD This Doctor is OpenDoctor Recommended.
	Dr. Kristin M. Hudock, MD This Doctor is OpenDoctor Recommended.
	Dr. Sigrid C. Veasey, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog